LeMaitre Vascular, Inc. (LMAT) Q1 2023 Earnings Results

Lemaitre Vascular Beats on EPS, Stock Up 0.15%

Lemaitre Vascular's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The company did not provide revenue figures or future guidance, leaving investors with limited information on growth expectations. The stock's modest rise reflects cautious optimism among investors following the earnings announcement.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.27	N/A	+6.30%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. They emphasized the importance of innovation in maintaining competitive advantage.

Management highlighted strong demand for their vascular products.

They noted ongoing investments in R&D to drive future growth.

Lemaitre Vascular Beats on EPS, Stock Up 0.15%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Beats on EPS, Stock Up 0.15%

Key numbers

Management commentary